Provided by Tiger Trade Technology Pte. Ltd.

NEUROONE MEDICAL TECH

0.9746
-0.0105-1.07%
Volume:7K
Turnover:6.40K
Market Cap:8.87M
PE:-1.02
High:0.9746
Open:0.9746
Low:0.9746
Close:0.9851
52wk High:6.96
52wk Low:0.9615
Shares:9.11M
Float Shares:6.24M
Volume Ratio:19.34
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9571
EPS(LYR):-0.5387
ROE:-124.66%
ROA:-58.07%
PB:2.36
PE(LYR):-1.81

Loading ...

Mar 05, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 28, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 21, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 09, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Oct 06, 2020

Major Issues Report

8-K - Current report
Sep 03, 2020

Major Issues Report

8-K - Current report
Aug 27, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 03, 2020

Major Issues Report

8-K - Current report
Jul 28, 2020

Major Issues Report

8-K - Current report